1085 related articles for article (PubMed ID: 26968346)
1. The Autophagy-Lysosomal Pathway in Neurodegeneration: A TFEB Perspective.
Martini-Stoica H; Xu Y; Ballabio A; Zheng H
Trends Neurosci; 2016 Apr; 39(4):221-234. PubMed ID: 26968346
[TBL] [Abstract][Full Text] [Related]
2. TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunities.
Cortes CJ; La Spada AR
Neurobiol Dis; 2019 Feb; 122():83-93. PubMed ID: 29852219
[TBL] [Abstract][Full Text] [Related]
3. The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases.
Jiao F; Zhou B; Meng L
CNS Neurosci Ther; 2023 Jan; 29(1):37-59. PubMed ID: 36184826
[TBL] [Abstract][Full Text] [Related]
4. Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia.
Liu Y; Xue X; Zhang H; Che X; Luo J; Wang P; Xu J; Xing Z; Yuan L; Liu Y; Fu X; Su D; Sun S; Zhang H; Wu C; Yang J
Autophagy; 2019 Mar; 15(3):493-509. PubMed ID: 30304977
[TBL] [Abstract][Full Text] [Related]
5. Trehalose causes low-grade lysosomal stress to activate TFEB and the autophagy-lysosome biogenesis response.
Jeong SJ; Stitham J; Evans TD; Zhang X; Rodriguez-Velez A; Yeh YS; Tao J; Takabatake K; Epelman S; Lodhi IJ; Schilling JD; DeBosch BJ; Diwan A; Razani B
Autophagy; 2021 Nov; 17(11):3740-3752. PubMed ID: 33706671
[TBL] [Abstract][Full Text] [Related]
6. TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications.
Gu Z; Cao H; Zuo C; Huang Y; Miao J; Song Y; Yang Y; Zhu L; Wang F
Neurobiol Dis; 2022 Oct; 173():105855. PubMed ID: 36031168
[TBL] [Abstract][Full Text] [Related]
7. Celastrol, a TFEB (transcription factor EB) agonist, is a promising drug candidate for Alzheimer disease.
Zhang W; Wang J; Yang C
Autophagy; 2022 Jul; 18(7):1740-1742. PubMed ID: 35253615
[TBL] [Abstract][Full Text] [Related]
8. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB.
Polito VA; Li H; Martini-Stoica H; Wang B; Yang L; Xu Y; Swartzlander DB; Palmieri M; di Ronza A; Lee VM; Sardiello M; Ballabio A; Zheng H
EMBO Mol Med; 2014 Sep; 6(9):1142-60. PubMed ID: 25069841
[TBL] [Abstract][Full Text] [Related]
9. TFEB-mediated Enhancement of the Autophagy-lysosomal Pathway Dually Modulates the Process of Amyloid β-Protein Generation in Neurons.
Yamamoto F; Taniguchi K; Mamada N; Tamaoka A; Kametani F; Lakshmana MK; Araki W
Neuroscience; 2019 Mar; 402():11-22. PubMed ID: 30677488
[TBL] [Abstract][Full Text] [Related]
10. The important role of TFEB in autophagy-lysosomal pathway and autophagy-related diseases: a systematic review.
Song TT; Cai RS; Hu R; Xu YS; Qi BN; Xiong YA
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1641-1649. PubMed ID: 33629334
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Potential of Vital Transcription Factors in Alzheimer's and Parkinson's Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy.
Rai SN; Tiwari N; Singh P; Mishra D; Singh AK; Hooshmandi E; Vamanu E; Singh MP
Front Neurosci; 2021; 15():777347. PubMed ID: 34970114
[TBL] [Abstract][Full Text] [Related]
12. A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition.
Song JX; Sun YR; Peluso I; Zeng Y; Yu X; Lu JH; Xu Z; Wang MZ; Liu LF; Huang YY; Chen LL; Durairajan SS; Zhang HJ; Zhou B; Zhang HQ; Lu A; Ballabio A; Medina DL; Guo Z; Li M
Autophagy; 2016 Aug; 12(8):1372-89. PubMed ID: 27172265
[TBL] [Abstract][Full Text] [Related]
13. Activation of ROS-PERK-TFEB by filbertone ameliorates neurodegenerative diseases via enhancing the autophagy-lysosomal pathway.
Park J; Gong JH; Chen Y; Nghiem TT; Chandrawanshi S; Hwang E; Yang CH; Kim BS; Park JW; Ryter SW; Ahn B; Joe Y; Chung HT; Yu R
J Nutr Biochem; 2023 Aug; 118():109325. PubMed ID: 36958418
[TBL] [Abstract][Full Text] [Related]
14. Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice.
Chao X; Wang S; Zhao K; Li Y; Williams JA; Li T; Chavan H; Krishnamurthy P; He XC; Li L; Ballabio A; Ni HM; Ding WX
Gastroenterology; 2018 Sep; 155(3):865-879.e12. PubMed ID: 29782848
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Quality Control via the PGC1α-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin.
Siddiqui A; Bhaumik D; Chinta SJ; Rane A; Rajagopalan S; Lieu CA; Lithgow GJ; Andersen JK
J Neurosci; 2015 Sep; 35(37):12833-44. PubMed ID: 26377470
[TBL] [Abstract][Full Text] [Related]
16. Brain Disorders Due to Lysosomal Dysfunction.
Fraldi A; Klein AD; Medina DL; Settembre C
Annu Rev Neurosci; 2016 Jul; 39():277-95. PubMed ID: 27090953
[TBL] [Abstract][Full Text] [Related]
17. Ligand-activated progesterone receptor B activates transcription factor EB to promote autophagy in human breast cancer cells.
Tan S; Bajalovic N; Wong ESP; Lin VCL
Exp Cell Res; 2019 Sep; 382(1):111433. PubMed ID: 31100306
[TBL] [Abstract][Full Text] [Related]
18. TFEB Participates in the Aβ-Induced Pathogenesis of Alzheimer's Disease by Regulating the Autophagy-Lysosome Pathway.
Zhang YD; Zhao JJ
DNA Cell Biol; 2015 Nov; 34(11):661-8. PubMed ID: 26368054
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor p53 regulates autophagosomal and lysosomal biogenesis in lung cancer cells by targeting transcription factor EB.
Zhang Z; Wang H; Ding Q; Xing Y; Xu D; Xu Z; Zhou T; Qian B; Ji C; Pan X; Zhong A; Ying Z; Zhou C; Shi M
Biomed Pharmacother; 2017 May; 89():1055-1060. PubMed ID: 28292013
[TBL] [Abstract][Full Text] [Related]
20. Evaluating and modulating TFEB in the control of autophagy: toward new treatments in CNS disorders.
da Costa A; Metais T; Mouthon F; Kerkovich D; Charvériat M
Fundam Clin Pharmacol; 2021 Jun; 35(3):539-551. PubMed ID: 33259088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]